Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Ralometostat · TNG-908

Small molecule · Inhibitor of protein arginine methyltransferase 5 (PRMT5) · developed by Tango Therapeutics

Phase 1/2 Most advanced trial (none active)
TNGX Developer
1 Registered trials

What is Ralometostat?

Ralometostat is an orally available small molecule that selectively binds and inhibits PRMT5, a methyltransferase that catalyzes arginine methylation of histones and other proteins. It is being studied in locally advanced solid tumors, with MTAP-deleted cancer cells showing particular sensitivity to PRMT5 inhibition.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
TNG-908
Drug type
Small molecule
Targets
protein arginine methyltransferase 5 (PRMT5), methylthioadenosine phosphorylase (MTAP) (biomarker)
Mechanism
Inhibitor of protein arginine methyltransferase 5 (PRMT5)
Pathways
histone arginine methylation, gene expression regulation of cell proliferation
Therapy area
Oncology
Developer
Tango Therapeutics, Inc. (TNGX)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1/2
UNII
X7CRL5YNN5

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05275478 Phase 1/2 Locally Advanced Solid Tumor Terminated TNGX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Locally Advanced Solid Tumor

Other drugs acting on PRMT5

More from Tango Therapeutics

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the TNGX page.

Follow TNGX, the company behind Ralometostat

See TNGX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

TNGX catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.